Blueshift Asset Management, LLC Edwards Lifesciences Corp Transaction History

Blueshift Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$69.28 - $93.38 $227,861 - $307,126	3,289 New	3,289 $227,000
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $190,625 - $216,937	2,567 New	2,567 $212,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $418,933 - $545,676	5,086 New	5,086 $420,000
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $271,888 - $324,305	-2,642 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $221,505 - $276,775	2,642 New	2,642 $274,000
Q1 2021 May 06, 2021	SELL	$78.68 - $90.67 $2.62 Million - $3.02 Million	-33,257 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $2.38 Million - $3.03 Million	33,257 New	33,257 $3.03 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $133,330 - $154,068	-2,392 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $308,315 - $412,353	-6,438 Reduced 72.91%	2,392 $458,000
Q4 2018 Feb 12, 2019	BUY	$46.41 - $56.94 $409,800 - $502,780	8,830 New	8,830 $1.35 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.